To me its always the politics of research, making research firms rich is as cutthroat as it gets (just look at Texas and UC Davis collaboration). I believe Mymetics has always wanted more for the company than the price big pharma wanted to pay. The decisions makers (for the sale)are the investors that own the company (Round) and they have about 60 to 75 million invested. I would think that thy would want at least 200 million for the company. That seems not to be happening and the owners will probably sell for a lot less at this time. Bottom line they probably want at least their money back. That would mean .15 to .18 a share and everyone goes home. I'm going to wait a bit more for that to happen. I believe the owners have always thought the virosome patents have a significant value and that was their ace-in-the-hole, if that is not the case at this point we are all in the toilet. In the meantime I probably have more capital gains in MYMX than any stock I own.
News 
Market Data 
Discover 
